| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash flows provided by financing activities | 5,590 | 5,592 |
| Net increase in cash | 1,918 | 2,819 |
| Cash and cash equivalents at beginning of period | 1,185 | - |
| Cash and cash equivalents at end of period | 3,103 | - |
PAVmed Inc. (PAVM)
PAVmed Inc. (PAVM)